53 phenotypes from 5 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Il2rbm1Btlr/Il2rbm1Btlr C57BL/6J-Il2rbm1Btlr	decreased B cell number	J:267694
	decreased CD4-positive, alpha-beta T cell number	J:267694
	decreased CD8-positive, naive alpha-beta T cell number	J:267694
	increased effector memory CD4-positive, alpha-beta T cell number	J:267694
	increased effector memory CD8-positive, alpha-beta T cell number	J:267694
Il2rbm2Btlr/Il2rbm2Btlr C57BL/6J-Il2rbm2Btlr	increased IgE level	J:272832
Il2rbM3Btlr/Il2rbM3Btlr C57BL/6J-Il2rbM3Btlr	abnormal CD8-positive, alpha-beta T cell differentiation	J:272833
	abnormal T cell morphology	J:272833
	decreased CD8-positive, alpha-beta T cell number	J:272833
	decreased central memory CD8 positive, alpha-beta T cell number	J:272833
	decreased NK cell number	J:272833
	decreased NK T cell number	J:272833
	increased CD4-positive, alpha-beta T cell number	J:272833
	increased IgM level	J:272833
Il2rbtm1b(EUCOMM)Hmgu/Il2rbtm1b(EUCOMM)Hmgu C57BL/6N-Il2rbtm1b(EUCOMM)Hmgu/Orl	abnormal autopod morphology	J:211773
	abnormal coat appearance	J:211773
	abnormal coat/ hair morphology	J:211773
	abnormal ear morphology	J:211773
	female infertility	J:211773
	male infertility	J:211773
Il2rbtm1Mak/Il2rbtm1Mak B6.129-Il2rbtm1Mak	abnormal lymphocyte morphology	J:113547
	abnormal response to transplant	J:113547
	abnormal spleen periarteriolar lymphoid sheath morphology	J:113547
	abnormal T cell activation	J:113547
	decreased regulatory T cell number	J:113547
	decreased T cell proliferation	J:113547
	enlarged lymph nodes	J:113547
	enlarged spleen	J:113547
	increased anti-double stranded DNA antibody level	J:113547
	increased susceptibility to autoimmune hemolytic anemia	J:113547
Il2rbtm1Mak/Il2rbtm1Mak C.129-Il2rbtm1Mak	abnormal immune system organ morphology	J:113547
	abnormal lymphocyte morphology	J:113547
	abnormal marginal zone B cell morphology	J:113547
	abnormal spleen periarteriolar lymphoid sheath morphology	J:113547
	abnormal T cell activation	J:113547
	abnormal T cell clonal deletion	J:113547
	decreased CD8-positive, alpha-beta T cell number	J:113547
	decreased T cell proliferation	J:113547
	enlarged lymph nodes	J:113547
	enlarged spleen	J:113547
	increased anti-double stranded DNA antibody level	J:113547
	increased susceptibility to autoimmune hemolytic anemia	J:113547
	liver inflammation	J:113547
	premature death	J:113547
Il2rbtm1Mak/Il2rbtm1Mak D2.129-Il2rbtm1Mak	abnormal T cell clonal deletion	J:113547
Il2rbtm1Mak/Il2rbtm1Mak either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas)	abnormal B cell activation	J:25940
	abnormal common myeloid progenitor cell morphology	J:25940
	abnormal hair texture	J:25940
	abnormal locomotor behavior	J:25940
	abnormal mononuclear cell morphology	J:25940
	abnormal sex gland morphology	J:25940
	abnormal T cell activation	J:25940
	decreased B cell number	J:25940
	decreased double-positive T cell number	J:25940
	decreased memory T cell number	J:25940
	enlarged lymph nodes	J:25940
	enlarged spleen	J:25940
	increased activated T cell number	J:25940
	increased anti-nuclear antigen antibody level	J:25940
	increased CD4-positive, alpha-beta T cell number	J:25940
	increased CD8-positive, alpha-beta T cell number	J:25940
	increased erythroid progenitor cell number	J:25940
	increased granulocyte number	J:25940
	increased IgE level	J:25940
	increased IgG1 level	J:25940
	increased neutrophil cell number	J:25940
	increased plasma cell number	J:25940
	increased susceptibility to autoimmune hemolytic anemia	J:25940
	premature death	J:25940
	thymus hypoplasia	J:25940
	weight loss	J:25940